132 related articles for article (PubMed ID: 17263879)
1. Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting.
Reithinger R; Coleman PG
BMC Infect Dis; 2007 Jan; 7():3. PubMed ID: 17263879
[TBL] [Abstract][Full Text] [Related]
2. Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004.
Vega JC; Sanchez BF; Montero LM; Montaña R; Del Pilar Mahecha M; Dueñes B; Baron AR; Reithinger R
Trop Med Int Health; 2007 Dec; 12(12):1540-4. PubMed ID: 18076562
[TBL] [Abstract][Full Text] [Related]
3. Health economic evaluation of moist wound care in chronic cutaneous leishmaniasis ulcers in Afghanistan.
Stahl HC; Ahmadi F; Nahzat SM; Dong HJ; Stahl KW; Sauerborn R
Infect Dis Poverty; 2018 Feb; 7(1):12. PubMed ID: 29444705
[TBL] [Abstract][Full Text] [Related]
4. Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan.
Aerts C; Vink M; Pashtoon SJ; Nahzat S; Picado A; Cruz I; Sicuri E
Appl Health Econ Health Policy; 2019 Apr; 17(2):213-230. PubMed ID: 30465319
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.
Reithinger R; Mohsen M; Wahid M; Bismullah M; Quinnell RJ; Davies CR; Kolaczinski J; David JR
Clin Infect Dis; 2005 Apr; 40(8):1148-55. PubMed ID: 15791515
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia.
Cardona-Arias JA; López-Carvajal L; Tamayo-Plata MP; Vélez ID
BMC Public Health; 2018 Jan; 18(1):185. PubMed ID: 29378537
[TBL] [Abstract][Full Text] [Related]
7. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
8. "Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.
Eid Rodríguez D; San Sebastian M; Pulkki-Brännström AM
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007788. PubMed ID: 31693661
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of a latrine revision programme in Kabul, Afghanistan.
Meddings DR; Ronald LA; Marion S; Pinera JF; Oppliger A
Bull World Health Organ; 2004 Apr; 82(4):281-9. PubMed ID: 15259257
[TBL] [Abstract][Full Text] [Related]
11. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan.
Reithinger R; Mohsen M; Aadil K; Sidiqi M; Erasmus P; Coleman PG
Emerg Infect Dis; 2003 Jun; 9(6):727-9. PubMed ID: 12781016
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
[TBL] [Abstract][Full Text] [Related]
13. The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: 'bringing down the neighbourhood'.
Reyburn H; Rowland M; Mohsen M; Khan B; Davies C
Trans R Soc Trop Med Hyg; 2003; 97(2):170-6. PubMed ID: 14584372
[TBL] [Abstract][Full Text] [Related]
14. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of treating multidrug-resistant tuberculosis.
Resch SC; Salomon JA; Murray M; Weinstein MC
PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of prevention strategies for American tegumentary leishmaniasis in Argentina.
Orellano PW; Vazquez N; Salomon OD
Cad Saude Publica; 2013 Dec; 29(12):2459-72. PubMed ID: 24356692
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
18. Orthopaedic trauma care in Haiti: a cost-effectiveness analysis of an innovative surgical residency program.
Carlson LC; Slobogean GP; Pollak AN
Value Health; 2012; 15(6):887-93. PubMed ID: 22999139
[TBL] [Abstract][Full Text] [Related]
19. Operational and economic evaluation of an NGO-led sexually transmitted infections intervention: north-western Cambodia.
Carrara V; Terris-Prestholt F; Kumaranayake L; Mayaud P
Bull World Health Organ; 2005 Jun; 83(6):434-42. PubMed ID: 15976894
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
Munir A; Janjua SA; Hussain I
Acta Dermatovenerol Croat; 2008; 16(2):60-4. PubMed ID: 18541100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
